Warberg Asset Management »

Regentis Biomaterials shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Regentis Biomaterials shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Regentis Biomaterials

Tip: Access up to 7 years of quarterly data

All positions including Regentis Biomaterials held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regentis Biomaterials by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $127k 19k 6.65

More positions owned by Warberg Asset Management

Spdr S&p 500 Etf Tr Put Put Option
Axon Enterprise Note 0.500%12/1 (Principal)
Invesco Qqq Tr Put Put Option
Western Digital Corp Note 3.000%11/1 (Principal)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Box Note 1/1 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Post Hldgs Note 2.500% 8/1 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)

View all positions for Warberg Asset Management

Top funds holding Regentis Biomaterials

Rosalind Advisors
Warberg Asset Management

View all funds holding Regentis Biomaterials